Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/09/2020 21 11
Atazanavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020 6 1
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/25/2020 19 5
Calcitriol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/18/2020 2 0
Vitamin D3 Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/12/2020 2 0
[(2S,3S,4S,5S)-5-Hydroxy-3,4-bis(pyridine-3-carbonyloxy)-5-(pyridine-3-carbonyloxymethyl)oxolan-2-yl]methyl pyridine-3-carboxylate Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020 1 0
(5S,5Ar,8aR,9S)-5-[[(2S,4aR,6R,7S,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020 1 0
Gliquidone Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/17/2020 1 0
Piperine Potential treatment - theoretical effect Natural product Antiviral Sep/17/2020 1 0